Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-18 Purchase |
2020-11-20 4:28 pm |
NEPHROS INC | NEPH | Spandow Oliver J. Director |
1,500 | $5.8328 | $8,749 | 35,929 (Direct) |
View |
| 2020-11-19 Purchase |
2020-11-19 6:17 pm |
NEPHROS INC | NEPH | Astor Andrew President & CEO |
1,000 | $5.8669 | $5,867 | 398,540 (Direct) |
View |
| 2020-08-19 Purchase |
2020-08-19 6:22 pm |
NEPHROS INC | NEPH | Astor Andrew COO/CFO |
950 | $7.4 | $7,030 | 245,476 (Direct) |
View |
| 2020-05-28 Purchase |
2020-05-29 6:08 pm |
NEPHROS INC | NEPH | Astor Andrew CFO/COO |
1,000 | $6.96 | $6,960 | 244,526 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-01 Exercise |
2021-06-03 4:41 pm |
2016-06-03 2021-06-03 |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
66,667 | $2.7 | 3,650,529 (Indirect) |
View |
| 2021-05-27 Tax Withholding(A) |
2021-06-01 5:39 pm |
N/A N/A |
NEPHROS INC | NEPH | Evans Daron CEO Specialty Renal Products |
349 | $2.7 | 8,669 (Indirect) |
View |
| 2021-05-24 Exercise |
2021-05-25 3:40 pm |
N/A N/A |
NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product |
1,111 | $2.7 | 524,458 (Indirect) |
View |
| 2021-05-24 Exercise |
2021-05-25 3:40 pm |
2016-06-03 2021-06-03 |
NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product |
2,222 | $0 | 524,458 (Indirect) |
View |
| 2021-02-16 Option Award |
2021-02-18 5:48 pm |
N/A 2031-02-16 |
NEPHROS INC | NEPH | Lobo Wesley S. Chief Marketing Officer |
154,735 | $0 | 154,735 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:49 pm |
N/A N/A |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
2,956 | $4.14 | 120,791 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:49 pm |
N/A N/A |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
3,765 | $3.6 | 120,791 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:49 pm |
N/A N/A |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
4,477 | $4.5 | 120,791 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:49 pm |
N/A N/A |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
3,556 | $4.59 | 120,791 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-29 4:49 pm |
2014-03-24 2021-01-29 |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
14,754 | $0 | 120,791 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 5:41 pm |
N/A N/A |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
3,196 | $0 | 3,196 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 5:32 pm |
N/A 2031-01-06 |
NEPHROS INC | NEPH | Gwydir Tom Director |
10,516 | $0 | 28,076 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 5:31 pm |
N/A 2031-01-06 |
NEPHROS INC | NEPH | Lask Alisa Director |
10,516 | $0 | 29,178 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 5:31 pm |
N/A 2031-01-06 |
NEPHROS INC | NEPH | PERSEN MALCOLM C Director |
12,771 | $0 | 86,121 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 5:31 pm |
N/A 2031-01-06 |
NEPHROS INC | NEPH | Spandow Oliver J. Director |
10,516 | $0 | 46,445 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 5:30 pm |
N/A 2031-01-06 |
NEPHROS INC | NEPH | AMRON ARTHUR H Director |
10,516 | $0 | 10,516 (Direct) |
View |
Ownership |
2020-11-10 6:03 pm |
N/A 2030-10-19 |
NEPHROS INC | NEPH | D'Agostino Daniel S. Chief Financial Officer |
0 | $0 | 103,973 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-16 4:38 pm |
N/A N/A |
NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner |
166,667 | $6 | 3,606,796 (Indirect) |
View |
| 2020-08-24 Option Award |
2020-08-26 4:33 pm |
N/A 2030-08-24 |
NEPHROS INC | NEPH | Astor Andrew President/CEO/CFO |
152,064 | $0 | 397,540 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 4:56 pm |
N/A N/A |
NEPHROS INC | NEPH | PERSEN MALCOLM C Director |
1,732 | $7.65 | 73,350 (Indirect) |
View |
| 2020-05-11 Exercise |
2020-05-13 4:56 pm |
2015-05-12 2020-05-18 |
NEPHROS INC | NEPH | PERSEN MALCOLM C Director |
1,732 | $0 | 73,350 (Indirect) |
View |